Article Details

Ascendiant Capital Markets Reiterates $8.25 Price Target for PAVmed (NASDAQ:PAVM)

Retrieved on: 2022-11-26 13:08:56

Tags for this article:

Click the tags to see associated articles and topics

Ascendiant Capital Markets Reiterates $8.25 Price Target for PAVmed (NASDAQ:PAVM). View article details on hiswai:

Excerpt

Millennium Management LLC acquired a new stake in shares of PAVmed in the second quarter valued at about $1,483,000. Vanguard Group Inc. boosted ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up